Thermo Fisher Scientific PODXL2 Monoclonal Antibody (211816)

Applications

Tested Dilution

Publications

Immunocytochemistry (ICC/IF)

8-25 µg/mL

-

Flow Cytometry (Flow)

2.5 µg per million cells

-

Product Specifications

Species Reactivity

Human

Host/Isotype

Mouse / IgG2a

Class

Monoclonal

Type

Antibody

Clone

211816

Immunogen

Mouse myeloma cell line NS0-derived recombinant human Endoglycan/PODXL2 Gly33-Thr500 if (typeof window.$mangular === undefined || !window.$mangular) { window.$mangular = {}; } $mangular.antigenJson = \[{targetFamily:PODXL2,uniProtId:Q9NZ53-1,ncbiNodeId:9606,antigenRange:33-500,antigenLength:605,antigenImageFileName:MA5-23932_PODXL2_Q9NZ53-1_House_mouse.svg,antigenImageFileNamePDP:MA5-23932_PODXL2_Q9NZ53-1_House_mouse_PDP.jpeg,sortOrder:1}\]; $mangular.isB2BCMGT = false; $mangular.isEpitopesModalImageMultiSizeEnabled = true;

View immunogen .st0{fill:#FFFFFF;} .st1{fill:#1E8AE7;}

Conjugate

Unconjugated Unconjugated Unconjugated

Form

Lyophilized

Concentration

0.5 mg/mL

Purification

Protein A/G

Storage buffer

PBS with 5% trehalose

Contains

No Preservative

Storage conditions

-20° C, Avoid Freeze/Thaw Cycles

Shipping conditions

Ambient (domestic); Wet ice (international)

RRID

AB_2576899

Product Specific Information

Reconstitute at 0.5 mg/mL in sterile PBS.

Target Information

Podolyxin is a CD34 family member expressed by podocytes, vascular endothelium, mesothelium, and a subset of hematopoietic progenitors. It is the major sialoprotein in the glycocalyx of glomerular podocytes. The physiologic role of podolyxin in leukemic blasts is unknown. However, it is thought of as a candidate prostate cancer tumor aggressiveness gene. Podolyxin appears to complement CD34 as a useful cell surface marker for hemangioblasts, the common precursors of hematopoietic and endothelial cells.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.